{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T01:40:42Z","timestamp":1791423642841,"version":"4.3.3"},"reference-count":102,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003135","name":"Fondation Fyssen","doi-asserted-by":"publisher","award":["081446"],"award-info":[{"award-number":["081446"]}],"id":[{"id":"10.13039\/501100003135","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["brainstimjrnl.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Stimulation"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.brs.2014.09.002","type":"journal-article","created":{"date-parts":[[2014,9,15]],"date-time":"2014-09-15T18:44:21Z","timestamp":1410806661000},"page":"27-35","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Interaction of Noradrenergic Pharmacological Manipulation and Subthalamic Stimulation on Movement Initiation Control in Parkinson's Disease"],"prefix":"10.1016","volume":"8","author":[{"given":"Marion","family":"Albares","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Thobois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Favre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Broussolle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo","family":"Polo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Domenech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Boulinguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9n\u00e9dicte","family":"Ballanger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brs.2014.09.002_bib1","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1474-4422(06)70373-8","article-title":"Non-motor symptoms of Parkinson's disease: diagnosis and management","volume":"5","author":"Chaudhuri","year":"2006","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.brs.2014.09.002_bib2","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1586\/ern.10.173","article-title":"Imaging cognitive and behavioral symptoms in Parkinson's disease","volume":"10","author":"Antonelli","year":"2010","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.brs.2014.09.002_bib3","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1002\/mds.23664","article-title":"Parkinson's disease: the quintessential neuropsychiatric disorder","volume":"26","author":"Weintraub","year":"2011","journal-title":"Mov Disord"},{"key":"10.1016\/j.brs.2014.09.002_bib4","first-page":"364","article-title":"Neurotransmission in Parkinson's disease: beyond dopamine","volume":"17","author":"Barone","year":"2010","journal-title":"Eur J\u00a0Neurol"},{"key":"10.1016\/j.brs.2014.09.002_bib5","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.nbd.2011.10.019","article-title":"Neurochemistry and the non-motor aspects of PD","volume":"46","author":"Ferrer","year":"2012","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.brs.2014.09.002_bib6","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00441-004-0956-9","article-title":"Stages in the development of Parkinson's disease-related pathology","volume":"318","author":"Braak","year":"2004","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.brs.2014.09.002_bib7","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.parkreldis.2009.08.007","article-title":"A\u00a0timeline for Parkinson's disease","volume":"16","author":"Hawkes","year":"2010","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.brs.2014.09.002_bib8","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s00702-012-0947-z","article-title":"Is there room for new non-dopaminergic treatments in Parkinson's disease?","volume":"120","author":"Pilleri","year":"2012","journal-title":"J\u00a0Neural Transm"},{"key":"10.1016\/j.brs.2014.09.002_bib9","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1007\/s40265-013-0105-4","article-title":"Non-dopaminergic treatments for motor control in Parkinson's disease","volume":"73","author":"Fox","year":"2013","journal-title":"Drugs"},{"key":"10.1016\/j.brs.2014.09.002_bib10","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/ana.24011","article-title":"Therapeutic prospects for Parkinson's disease","volume":"74","author":"Olanow","year":"2013","journal-title":"Ann Neurol"},{"key":"10.1016\/j.brs.2014.09.002_bib11","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1212\/WNL.0b013e3181b784e7","article-title":"Serotonergic modulation of basal ganglia circuits: complexity and therapeutic opportunities","volume":"73","author":"Benarroch","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.brs.2014.09.002_bib12","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1472-8206.2009.00798.x","article-title":"Dopaminergic and non-dopaminergic pharmacological hypotheses for gait disorders in Parkinson's disease","volume":"24","author":"Devos","year":"2010","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.brs.2014.09.002_bib13","first-page":"585","article-title":"Clinical neurophysiology of akinesia","volume":"146","author":"Hallett","year":"1990","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/j.brs.2014.09.002_bib14","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/s13311-012-0166-1","article-title":"Deep brain stimulation of the subthalamic nucleus, but not dopaminergic medication, improves proactive inhibitory control of movement initiation in Parkinson's disease","volume":"10","author":"Favre","year":"2013","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.brs.2014.09.002_bib15","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson's disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.brs.2014.09.002_bib16","series-title":"Afferent connections to the subthalamic nucleus in the monkey and the cat studied with the HRP technique","first-page":"53","author":"Rinvik","year":"1979"},{"key":"10.1016\/j.brs.2014.09.002_bib17","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0006-8993(90)91087-W","article-title":"Afferent connections of the subthalamic nucleus: a combined retrograde and anterograde horseradish peroxidase study in the rat","volume":"513","author":"Canteras","year":"1990","journal-title":"Brain Res"},{"key":"10.1016\/j.brs.2014.09.002_bib18","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/0165-0173(94)00008-D","article-title":"Functional anatomy of the basal ganglia. II. The place of subthalamic nucleus and external pallidium in basal ganglia circuitry","volume":"20","author":"Parent","year":"1995","journal-title":"Brain Res Rev"},{"key":"10.1016\/j.brs.2014.09.002_bib19","doi-asserted-by":"crossref","first-page":"9595","DOI":"10.1523\/JNEUROSCI.2583-07.2007","article-title":"Noradrenergic modulation of subthalamic nucleus activity: behavioral and electrophysiological evidence in intact and 6-hydroxydopamine-lesioned rats","volume":"27","author":"Belujon","year":"2007","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.brs.2014.09.002_bib20","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3389\/fnsys.2011.00031","article-title":"Noradrenaline and Parkinson's disease","volume":"5","author":"Delaville","year":"2011","journal-title":"Front Syst Neurosci"},{"key":"10.1016\/j.brs.2014.09.002_bib21","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1136\/jnnp.2006.100016","article-title":"Improvement of gait by chronic, high doses of methylphenidate in patients with advanced Parkinson's disease","volume":"78","author":"Devos","year":"2007","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.brs.2014.09.002_bib22","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1093\/brain\/awq032","article-title":"Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation","volume":"133","author":"Thobois","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.brs.2014.09.002_bib23","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S1474-4422(12)70106-0","article-title":"Methylphenidate for gait hypokinesia and freezing in patients with Parkinson's disease undergoing subthalamic stimulation: a multicentre, parallel, randomised, placebo-controlled trial","volume":"11","author":"Moreau","year":"2012","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.brs.2014.09.002_bib24","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s00701-008-1619-5","article-title":"Noradrenergic modulation of subthalamic nucleus activity in human: metoprolol reduces spiking activity in microelectrode recordings during deep brain stimulation surgery for Parkinson's disease","volume":"150","author":"Coenen","year":"2008","journal-title":"Acta Neurochir"},{"key":"10.1016\/j.brs.2014.09.002_bib25","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.neuroscience.2012.02.026","article-title":"Lead intoxication induces noradrenaline depletion, motor nonmotor disabilities, and changes in the firing pattern of subthalamic nucleus neurons","volume":"210","author":"Sabbar","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.brs.2014.09.002_bib26","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.nbd.2011.10.023","article-title":"Emerging dysfunctions consequent to combined monoaminergic depletions in parkinsonism","volume":"45","author":"Delaville","year":"2012","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.brs.2014.09.002_bib27","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.brainresrev.2004.02.002","article-title":"Noradrenergic mechanisms in neurodegenerative diseases: a theory","volume":"45","author":"Marien","year":"2004","journal-title":"Brain Res Brain Res Rev"},{"key":"10.1016\/j.brs.2014.09.002_bib28","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.neurol.2009.06.003","article-title":"Assessment of hyper- and hypodopaminergic behaviours in Parkinson's disease","volume":"165","author":"Ardouin","year":"2009","journal-title":"Rev Neurol"},{"key":"10.1016\/j.brs.2014.09.002_bib29","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.brainres.2007.08.032","article-title":"Cueing method biases in visual detection studies","volume":"1179","author":"Jaffard","year":"2007","journal-title":"Brain Res"},{"key":"10.1016\/j.brs.2014.09.002_bib30","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.neuroimage.2008.05.041","article-title":"Proactive inhibitory control of movement assessed by event-related fMRI","volume":"42","author":"Jaffard","year":"2008","journal-title":"NeuroImage"},{"key":"10.1016\/j.brs.2014.09.002_bib31","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3389\/fpsyg.2012.00059","article-title":"Proactive inhibitory control of response as the default state of executive control","volume":"3","author":"Criaud","year":"2012","journal-title":"Front Psychol"},{"key":"10.1016\/j.brs.2014.09.002_bib32","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1152\/jn.01198.2007","article-title":"Warning signals induce automatic EMG activations and proactive volitional inhibition: evidence from analysis of error distribution in simple RT","volume":"99","author":"Boulinguez","year":"2008","journal-title":"J\u00a0Neurophysiol"},{"issue":"5","key":"10.1016\/j.brs.2014.09.002_bib33","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/mds.22735","article-title":"Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease","volume":"25","author":"Moro","year":"2010","journal-title":"Mov Disord"},{"key":"10.1016\/j.brs.2014.09.002_bib34","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.conb.2008.11.001","article-title":"Seven problems on the basal ganglia","volume":"18","author":"Nambu","year":"2008","journal-title":"Curr Opin Neurobiol"},{"key":"10.1016\/j.brs.2014.09.002_bib35","first-page":"5","article-title":"Past, present, and future of the pathophysiological model of the basal ganglia","volume":"12","author":"Obeso","year":"2011","journal-title":"Front Neuroanat"},{"key":"10.1016\/j.brs.2014.09.002_bib36","doi-asserted-by":"crossref","first-page":"4804","DOI":"10.1523\/JNEUROSCI.4674-12.2013","article-title":"The organization of prefrontal-subthalamic inputs in primates provides an anatomical substrate for both functional specificity and integration: implications for basal ganglia models and deep brain stimulation","volume":"33","author":"Haynes","year":"2013","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.brs.2014.09.002_bib37","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nn.3632","article-title":"Basal ganglia subcircuits distinctively encode the parsing and concatenation of action sequences","volume":"17","author":"Jin","year":"2014","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.brs.2014.09.002_bib38","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.brs.2013.06.002","article-title":"Locus coeruleus is involved in weight loss in a rat model of Parkinson's disease: an effect reversed by deep brain stimulation","volume":"6","author":"Guimar\u00e3es","year":"2013","journal-title":"Brain Stimul"},{"key":"10.1016\/j.brs.2014.09.002_bib39","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s13311-013-0239-9","article-title":"Treatment of Parkinson's disease: what's in the non-dopaminergic pipeline?","volume":"11","author":"Hung","year":"2013","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.brs.2014.09.002_bib40","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s13311-013-0242-1","article-title":"Therapy for Parkinson's disease: what is in the pipeline?","volume":"11","author":"Stocchi","year":"2013","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.brs.2014.09.002_bib41","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s13311-013-0235-0","article-title":"Surgical treatment of Parkinson's disease: patients, targets, devices, and approaches","volume":"11","author":"Wagle Shukla","year":"2013","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.brs.2014.09.002_bib42","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s13311-013-0218-1","article-title":"Pathogenesis-targeted, disease-modifying therapies in Parkinson disease","volume":"11","author":"AlDakheel","year":"2013","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.brs.2014.09.002_bib43","first-page":"594860","article-title":"Imaging impulsivity in Parkinson's disease and the contribution of the subthalamic nucleus","author":"Ray","year":"2011","journal-title":"Parkinsons Dis"},{"key":"10.1016\/j.brs.2014.09.002_bib44","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.pneurobio.2013.06.005","article-title":"Inhibition and impulsivity: behavioral and neural basis of response control","volume":"108","author":"Bari","year":"2013","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.brs.2014.09.002_bib45","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/ana.21795","article-title":"Stimulation of the subthalamic nucleus and impulsivity: release your horses","volume":"66","author":"Ballanger","year":"2009","journal-title":"Ann Neurol"},{"key":"10.1016\/j.brs.2014.09.002_bib46","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1126\/science.1146157","article-title":"Hold your horses: impulsivity, deep brain stimulation, and medication in parkinsonism","volume":"318","author":"Frank","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.brs.2014.09.002_bib47","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.jocn.2008.12.010","article-title":"Dopamine dysregulation syndrome, impulse control disorders and punding after deep brain stimulation surgery for Parkinson's disease","volume":"16","author":"Lim","year":"2009","journal-title":"J\u00a0Clin Neurosci"},{"key":"10.1016\/j.brs.2014.09.002_bib48","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00429-011-0314-0","article-title":"Impulse control disorders in Parkinson's disease: seeking a roadmap toward a better understanding","volume":"216","author":"Cilia","year":"2011","journal-title":"Brain Struct Funct"},{"key":"10.1016\/j.brs.2014.09.002_bib49","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.1093\/brain\/awq256","article-title":"Mapping Go-No-Go performance within the subthalamic nucleus region","volume":"133","author":"Hershey","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.brs.2014.09.002_bib50","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/0166-2236(90)90107-L","article-title":"Functional architecture of basal ganglia circuits: neural substrates of parallel processing","volume":"13","author":"Alexander","year":"1990","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.brs.2014.09.002_bib51","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0301-0082(96)00042-1","article-title":"The basal ganglia: focused selection and inhibition of competing motor programs","volume":"50","author":"Mink","year":"1996","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.brs.2014.09.002_bib52","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0168-0102(02)00027-5","article-title":"Functional significance of the cortico-subthalamo-pallidal \u201chyperdirect\u201d pathway","volume":"43","author":"Nambu","year":"2002","journal-title":"Neurosci Res"},{"key":"10.1016\/j.brs.2014.09.002_bib53","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0079-6123(03)43043-4","article-title":"A\u00a0new dynamic model of the cortico-basal ganglia loop","volume":"143","author":"Nambu","year":"2004","journal-title":"Prog Brain Res"},{"key":"10.1016\/j.brs.2014.09.002_bib54","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neubiorev.2012.11.003","article-title":"Have we been asking the right questions when assessing response inhibition in go\/no-go tasks with fMRI? A meta-analysis and critical review","volume":"37","author":"Criaud","year":"2013","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.brs.2014.09.002_bib55","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.tics.2010.01.006","article-title":"Switching from automatic to controlled behavior: cortico-basal ganglia mechanisms","volume":"14","author":"Hikosaka","year":"2010","journal-title":"Trends Cogn Sci"},{"key":"10.1016\/j.brs.2014.09.002_bib56","doi-asserted-by":"crossref","first-page":"15916","DOI":"10.1073\/pnas.1004932107","article-title":"Cortico-striatal connections predict control over speed and accuracy in perceptual decision making","volume":"107","author":"Forstmann","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.brs.2014.09.002_bib57","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1037\/a0031497","article-title":"Unconsciously triggered response inhibition requires an executive setting","volume":"143","author":"Chiu","year":"2014","journal-title":"J\u00a0Exp Psychol Gen"},{"key":"10.1016\/j.brs.2014.09.002_bib58","doi-asserted-by":"crossref","first-page":"15815","DOI":"10.1523\/JNEUROSCI.1790-13.2013","article-title":"Cognitive factors modulate activity within the human subthalamic nucleus during voluntary movement in Parkinson's disease","volume":"33","author":"Oswal","year":"2013","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.brs.2014.09.002_bib59","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1093\/brain\/awh106","article-title":"Event-related beta desynchronization in human subthalamic nucleus correlates with motor performance","volume":"127","author":"K\u00fchn","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.brs.2014.09.002_bib60","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.neuroimage.2013.10.070","article-title":"Subthalamic nucleus activity dissociates proactive and reactive inhibition in patients with Parkinson's disease","volume":"91","author":"Benis","year":"2014","journal-title":"Neuroimage"},{"key":"10.1016\/j.brs.2014.09.002_bib61","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00221-006-0783-1","article-title":"Perceptual factors contribute to akinesia in Parkinson's disease","volume":"179","author":"Ballanger","year":"2007","journal-title":"Exp Brain Res"},{"key":"10.1016\/j.brs.2014.09.002_bib62","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0079-6123(00)26030-5","article-title":"From arousal to cognition: the integrative position of the prefrontal cortex","volume":"126","author":"Robbins","year":"2000","journal-title":"Prog Brain Res"},{"key":"10.1016\/j.brs.2014.09.002_bib63","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1126\/science.283.5401.549","article-title":"The role of locus coeruleus in the regulation of cognitive performance","volume":"283","author":"Usher","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.brs.2014.09.002_bib64","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nrn2573","article-title":"The locus coeruleus and noradrenergic modulation of cognition","volume":"10","author":"Sara","year":"2009","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.brs.2014.09.002_bib65","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1146\/annurev-neuro-062111-150525","article-title":"The attention system of the human brain: 20 years after","volume":"35","author":"Petersen","year":"2012","journal-title":"Annu Rev Neurosci"},{"key":"10.1016\/j.brs.2014.09.002_bib66","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/cne.20723","article-title":"Adaptive gain and the role of the locus coeruleus-norepinephrine system in optimal performance","volume":"493","author":"Aston-Jones","year":"2005","journal-title":"J\u00a0Comp Neurol"},{"key":"10.1016\/j.brs.2014.09.002_bib67","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1152\/jn.00206.2011","article-title":"Attention to baseline: does orienting visuospatial attention really facilitate target detection?","volume":"106","author":"Albares","year":"2011","journal-title":"J\u00a0Neurophysiol"},{"key":"10.1016\/j.brs.2014.09.002_bib68","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1177\/0269881113480988","article-title":"Noradrenergic modulation of cognition: therapeutic implications","volume":"27","author":"Chamberlain","year":"2013","journal-title":"J\u00a0Psychopharmacol"},{"key":"10.1016\/j.brs.2014.09.002_bib69","doi-asserted-by":"crossref","first-page":"S145","DOI":"10.1002\/mds.10156","article-title":"Intraoperative microrecordings of the subthalamic nucleus in Parkinson's disease","volume":"17","author":"Benazzouz","year":"2002","journal-title":"Mov Disord"},{"key":"10.1016\/j.brs.2014.09.002_bib70","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/ana.410440407","article-title":"Neurophysiological identification of the subthalamic nucleus in surgery for Parkinson's disease","volume":"44","author":"Hutchinson","year":"1998","journal-title":"Ann Neurol"},{"issue":"S1","key":"10.1016\/j.brs.2014.09.002_bib71","first-page":"S134","article-title":"Noradrenergic modulation of movement initiation control in Parkinson's disease: a pharmacological fMRI study with clonidine","volume":"29","author":"Ballanger","year":"2014","journal-title":"Mov Disord"},{"key":"10.1016\/j.brs.2014.09.002_bib72","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1471-4159.2004.02866.x","article-title":"Stimulation of the locus coeruleus elicits noradrenaline and dopamine release in the medial prefrontal and parietal cortex","volume":"92","author":"Devoto","year":"2005","journal-title":"J\u00a0Neurochem"},{"key":"10.1016\/j.brs.2014.09.002_bib73","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.neuroscience.2005.09.031","article-title":"Noradrenergic modulation of cognitive function in rat medial prefrontal cortex as measured by attentional set shifting capability","volume":"137","author":"Lapiz","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.brs.2014.09.002_bib74","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.brs.2013.03.009","article-title":"Sex, food and threat: startling changes after subthalamic stimulation in Parkinson's disease","volume":"6","author":"Serranov\u00e1","year":"2013","journal-title":"Brain Stimul"},{"key":"10.1016\/j.brs.2014.09.002_bib75","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/nrneurol.2010.111","article-title":"Neuropsychiatric effects of subthalamic neurostimulation in Parkinson disease","volume":"6","author":"Volkmann","year":"2010","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.brs.2014.09.002_bib76","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1093\/brain\/awq301","article-title":"Involvement of the subthalamic nucleus in impulse control disorders associated with Parkinson's disease","volume":"134","author":"Rodriguez-Oroz","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.brs.2014.09.002_bib77","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S1474-4422(13)70294-1","article-title":"Review mood and behavioural effects of subthalamic stimulation in Parkinson's disease","volume":"13","author":"Catsrioto","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.brs.2014.09.002_bib78","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1001\/archneurol.2009.294","article-title":"Dopamine agonist withdrawal syndrome in Parkinson disease","volume":"67","author":"Rabinak","year":"2010","journal-title":"Arch Neurol"},{"key":"10.1016\/j.brs.2014.09.002_bib79","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1136\/jnnp-2012-302684","article-title":"Clinical features of dopamine agonist withdrawal syndrome in a movement disorders clinic","volume":"84","author":"Pondal","year":"2013","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.brs.2014.09.002_bib80","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1136\/jnnp-2012-303570","article-title":"Dopamine agonist withdrawal syndrome (DAWS): perils of flicking the dopamine \u201cswitch\u201d","volume":"84","author":"Edwards","year":"2013","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.brs.2014.09.002_bib81","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1111\/j.1460-9568.2012.08029.x","article-title":"Presynaptic inhibition of glutamate transmission by \u03b12 receptors in the VTA","volume":"35","author":"Jim\u00e9nez-Rivera","year":"2012","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.brs.2014.09.002_bib82","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neubiorev.2005.03.024","article-title":"Dopaminergic modulation of cognitive function-implications for l-DOPA treatment in Parkinson's disease","volume":"30","author":"Cools","year":"2006","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.brs.2014.09.002_bib83","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1089\/cap.2013.0028","article-title":"A\u00a0review of the rationale and clinical utilization of \u03b12-adrenoceptor agonists for the treatment of attention-deficit\/hyperactivity and related disorders","volume":"23","author":"Sallee","year":"2013","journal-title":"J\u00a0Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.brs.2014.09.002_bib84","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1155\/2013\/626410","article-title":"Trials of pharmacological interventions for Tourette syndrome: a systematic review","volume":"26","author":"Waldon","year":"2013","journal-title":"Behav Neurol"},{"key":"10.1016\/j.brs.2014.09.002_bib85","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s11940-010-0095-4","article-title":"Treatment of tics and Tourette syndrome","volume":"12","author":"Singer","year":"2010","journal-title":"Curr Treat Options Neurol"},{"key":"10.1016\/j.brs.2014.09.002_bib86","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.neubiorev.2012.09.008","article-title":"Systematic review: pharmacological treatment of tic disorders \u2013 efficacy of antipsychotic and alpha-2 adrenergic agonist agents","volume":"37","author":"Weisman","year":"2013","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.brs.2014.09.002_bib87","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/0028-3908(87)90110-9","article-title":"Pharmacological characteristics of tremor, rigidity and hypokinesia induced by reserpine in rat","volume":"26","author":"Colpaert","year":"1987","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.brs.2014.09.002_bib88","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/S0278-5846(99)00067-6","article-title":"Effect of the alpha 2 adrenoreceptor antagonist, idazoxan, on motor disabilities in MPTP-treated monkey","volume":"23","author":"Bezard","year":"1999","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.brs.2014.09.002_bib89","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1002\/mds.10464","article-title":"Fipamezole (JP-1730) is a potent alpha2 adrenergic receptor antagonist that reduces levodopa-induced dyskinesia in the MPTP-lesioned primate model of Parkinson's disease","volume":"18","author":"Savola","year":"2003","journal-title":"Mov Disord"},{"key":"10.1016\/j.brs.2014.09.002_bib90","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/1531-8257(199909)14:5<744::AID-MDS1006>3.0.CO;2-7","article-title":"The alpha2-adrenergic receptor antagonist idazoxan reduces dyskinesia and enhances anti-parkinsonian actions of L-dopa in the MPTP-lesioned primate model of Parkinson's disease","volume":"14","author":"Henry","year":"1999","journal-title":"Mov Disord"},{"key":"10.1016\/j.brs.2014.09.002_bib91","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3109\/713745180","article-title":"Effects of (+\/\u2212)-idazoxan alone and in combination with L-DOPA methyl ester in MPTP-induced hemiparkinsonian monkeys","volume":"9","author":"Domino","year":"2003","journal-title":"Receptors Channels"},{"key":"10.1016\/j.brs.2014.09.002_bib92","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2165\/00023210-199810030-00004","article-title":"\u03b12-adrenoceptor antagonists","volume":"10","author":"Brefel-Courbon","year":"1998","journal-title":"CNS Drugs"},{"key":"10.1016\/j.brs.2014.09.002_bib93","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1002\/mds.1143","article-title":"Idazoxan, an alpha-2 antagonist, and L-DOPA-induced dyskinesias in patients with Parkinson's disease","volume":"16","author":"Rascol","year":"2001","journal-title":"Mov Disord"},{"issue":"5","key":"10.1016\/j.brs.2014.09.002_bib94","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1124\/mol.108.048033","article-title":"Cross-talk between dopaminergic and noradrenergic systems in the rat ventral tegmental area, locus ceruleus, and dorsal hippocampus","volume":"74","author":"Guiard","year":"2008","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.brs.2014.09.002_bib95","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/BF01252703","article-title":"Anatomical relationships between the ventral mesencephalic tegmentum\u2014a 10 region and the locus coeruleus as demonstrated by anterograde and retrograde tracing techniques","volume":"44","author":"Simon","year":"1979","journal-title":"J\u00a0Neural Transm"},{"key":"10.1016\/j.brs.2014.09.002_bib96","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0306-4522(97)00578-2","article-title":"Localization of alpha2C-adrenergic receptor immunoreactivity in catecholaminergic neurons in the rat central nervous system","volume":"84","author":"Lee","year":"1998","journal-title":"Neuroscience"},{"issue":"5","key":"10.1016\/j.brs.2014.09.002_bib97","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1017\/S1461145707008383","article-title":"Functional interactions between dopamine, serotonin and norepinephrine neurons: an in-vivo electrophysiological study in rats with monoaminergic lesions","volume":"11","author":"Guiard","year":"2008","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.brs.2014.09.002_bib98","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/BF01253597","article-title":"Biochemical and radioautographic evidence for dopaminergic afferents of the locus coeruleus originating in the ventral tegmental area","volume":"70","author":"Ornstein","year":"1987","journal-title":"J\u00a0Neural Transm"},{"issue":"3","key":"10.1016\/j.brs.2014.09.002_bib99","first-page":"287","article-title":"Iowa gambling task impairment in Parkinson's disease can be normalised by reduction of dopaminergic medication after subthalamic stimulation","volume":"13","author":"Castrioto","year":"2014","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"6","key":"10.1016\/j.brs.2014.09.002_bib100","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1002\/hbm.22344","article-title":"Dopamine-agonists and impulsivity in Parkinson's disease: impulsive choices vs. impulsive actions","volume":"35","author":"Antonelli","year":"2014","journal-title":"Hum Brain Mapp"},{"issue":"7","key":"10.1016\/j.brs.2014.09.002_bib101","first-page":"118","article-title":"Effects of deep brain stimulation of the subthalamic nucleus on inhibitory and executive control over prepotent responses in Parkinson's disease","volume":"25","author":"Jahanshahi","year":"2013","journal-title":"Front Syst Neurosci"},{"issue":"7","key":"10.1016\/j.brs.2014.09.002_bib102","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1093\/brain\/awu117","article-title":"Targeting impulsivity in Parkinson's disease using atomoxetine","volume":"137","author":"Kehagia","year":"2014","journal-title":"Brain"}],"container-title":["Brain Stimulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1935861X14003106?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1935861X14003106?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T14:05:59Z","timestamp":1761833159000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1935861X14003106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":102,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S1935861X14003106"],"URL":"https:\/\/doi.org\/10.1016\/j.brs.2014.09.002","relation":{},"ISSN":["1935-861X"],"issn-type":[{"value":"1935-861X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interaction of Noradrenergic Pharmacological Manipulation and Subthalamic Stimulation on Movement Initiation Control in Parkinson's Disease","name":"articletitle","label":"Article Title"},{"value":"Brain Stimulation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brs.2014.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}